Upgrade to SI Premium - Free Trial

Cingulate Inc (CING)

5.09 +0.20 (4.09%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/18/26)

Latest Headlines

Form 4 Cingulate Inc. For: Feb 13 Filed by: Hargroves Thomas Jeffrey June 8, 2026 7:02 PM - SEC Filing Form 3 Cingulate Inc. For: Feb 13 Filed by: Hargroves Thomas Jeffrey June 8, 2026 7:00 PM - SEC Filing Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26 June 4, 2026 4:50 PM - StreetInsider Form 8-K Cingulate Inc. For: Jun 02 June 2, 2026 8:10 AM - SEC Filing FDA issues complete response letter for Cingulate's ADHD drug CTx-1301 June 2, 2026 8:01 AM - StreetInsider Cingulate Receives Complete Response Letter from FDA for CTx-1301 June 2, 2026 8:00 AM - Globe NewsWire Cingulate Inc (CING) Halted News Pending June 2, 2026 7:59 AM - StreetInsider Form DEF 14A Cingulate Inc. For: May 29 May 29, 2026 9:17 AM - SEC Filing Form ARS Cingulate Inc. For: Dec 31 May 29, 2026 8:11 AM - SEC Filing Form DEFA14A Cingulate Inc. May 29, 2026 8:05 AM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Cingulate (CING) May 26, 2026 6:59 AM - StreetInsider Cingulate board to shrink to five directors after 2026 meeting May 19, 2026 4:53 PM - StreetInsider Form 8-K Cingulate Inc. For: May 18 May 19, 2026 4:50 PM - SEC Filing Form PRE 14A Cingulate Inc. For: May 18 May 19, 2026 10:14 AM - SEC Filing Form 10-Q Cingulate Inc. For: Mar 31 May 14, 2026 8:16 AM - SEC Filing Form 8-K Cingulate Inc. For: May 14 May 14, 2026 8:10 AM - SEC Filing Cingulate reports Q1 2026 results, raises $14.9M in cash May 14, 2026 8:03 AM - StreetInsider Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301 May 14, 2026 8:00 AM - Globe NewsWire Form 4 Cingulate Inc. For: Mar 31 Filed by: Silva Raul R. May 8, 2026 6:00 PM - SEC Filing Form 424B3 Cingulate Inc. April 28, 2026 4:25 PM - SEC Filing Form EFFECT Cingulate Inc. April 27, 2026 6:04 AM - SEC Filing Form S-3 Cingulate Inc. April 14, 2026 5:27 PM - SEC Filing Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25 April 6, 2026 4:36 PM - StreetInsider Form 8-K Cingulate Inc. For: Mar 27 April 2, 2026 4:06 PM - SEC Filing Form 424B3 Cingulate Inc. March 27, 2026 4:02 PM - SEC Filing Form EFFECT Cingulate Inc. March 27, 2026 6:06 AM - SEC Filing Form SCHEDULE 13D/A Cingulate Inc. Filed by: Falcon Creek Capital Advisor LLC March 26, 2026 4:24 PM - SEC Filing Form EFFECT Cingulate Inc. March 25, 2026 6:05 AM - SEC Filing Form 8-K Cingulate Inc. For: Mar 24 March 24, 2026 5:15 PM - SEC Filing Form 424B3 Cingulate Inc. March 24, 2026 5:13 PM - SEC Filing Cingulate (CING) PT Lowered to $14 at Roth/MKM March 23, 2026 9:11 AM - StreetInsider Form S-3/A Cingulate Inc. March 23, 2026 8:45 AM - SEC Filing Form S-3 Cingulate Inc. March 20, 2026 6:01 AM - SEC Filing Form DEFA14A Cingulate Inc. March 18, 2026 4:30 PM - SEC Filing Form 10-K Cingulate Inc. For: Dec 31 March 18, 2026 8:14 AM - SEC Filing Form 8-K Cingulate Inc. For: Mar 18 March 18, 2026 8:11 AM - SEC Filing Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights March 18, 2026 8:01 AM - Globe NewsWire Full Article List